Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine Group Medical Visits for Drug Users at Risk for HIV
NCT02526212Phase 3Completed
- Sponsor
- Montefiore Medical Center
- Start
- Jan 2017
- Primary completion
- May 2019
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial (2 arms), sponsored by Montefiore Medical Center. Primary endpoint: Number of Participants With Opioid Abstinence at 8 weeks. Started Jan 2017; status: completed.
Beyond the preview
Go deeper on NCT02526212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02526212.